InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
asp42001 Free
01/12/21 9:53 AM
profile icon
whytestocks Free
01/17/19 1:06 PM
profile icon
millionaireonpaper Free
04/27/18 10:56 AM
profile icon
ValueInvestor15 Free
02/01/17 9:22 AM
profile icon
shub Free
12/14/16 4:13 PM
profile icon
shub Free
12/14/16 3:51 PM
profile icon
TREND1 PremiumMember
09/21/16 12:28 PM
profile icon
TREND1 PremiumMember
09/21/16 12:25 PM
profile icon
TREND1 PremiumMember
09/21/16 12:24 PM
profile icon
TREND1 PremiumMember
09/21/16 12:23 PM
profile icon
TREND1 PremiumMember
09/21/16 12:22 PM
profile icon
Beehiving Free
06/11/16 12:46 PM
profile icon
MultiMillionare Free
08/24/15 3:08 PM
profile icon
BikerBob Free
03/05/15 11:35 AM
profile icon
BikerBob Free
03/05/15 9:55 AM
profile icon
BikerBob Free
02/08/15 11:39 AM
profile icon
56Chevy PremiumMember
02/06/15 2:06 PM
profile icon
BikerBob Free
02/06/15 8:55 AM
profile icon
56Chevy PremiumMember
02/05/15 5:06 PM
profile icon
BikerBob Free
02/05/15 11:54 AM
profile icon
DITRLI Free
10/06/14 9:52 AM
profile icon
ernie44 Free
01/25/14 12:27 PM
profile icon
ECole Free
07/16/13 10:53 AM
profile icon
investora2z Free
06/22/13 11:40 PM
profile icon
investora2z Free
06/22/13 7:39 AM
profile icon
Penny Roger$ Free
04/30/12 6:44 AM
profile icon
Penny Roger$ Free
04/30/12 6:44 AM
profile icon
Penny Roger$ Free
02/07/12 5:57 AM
profile icon
auroradude Free
09/28/10 8:14 PM
profile icon
auroradude Free
09/20/10 4:52 PM
profile icon
auroradude Free
08/19/10 9:19 PM
profile icon
Red Green Free
08/19/10 9:09 PM
profile icon
auroradude Free
08/18/10 3:51 PM
profile icon
auroradude Free
08/12/10 2:05 AM
profile icon
BlueChip Free
08/11/10 9:28 PM
profile icon
BlueChip Free
08/11/10 9:26 PM
profile icon
auroradude Free
08/11/10 9:16 PM
profile icon
BlueChip Free
08/11/10 9:02 PM
profile icon
BlueChip Free
08/11/10 9:01 PM
profile icon
auroradude Free
08/10/10 3:40 PM
profile icon
flyak27 Free
08/06/10 4:15 PM
profile icon
auroradude Free
08/06/10 2:56 PM
profile icon
auroradude Free
08/06/10 11:08 AM
profile icon
auroradude Free
08/02/10 6:13 PM
profile icon
auroradude Free
08/02/10 5:50 PM
profile icon
BikerBob Free
07/30/10 12:32 PM
profile icon
auroradude Free
07/28/10 12:03 AM

Becton, Dickinson and Company (BDX) RSS Feed

Followers
5
Posters
26
Posts (Today)
0
Posts (Total)
72
Created
04/07/08
Type
Free
Moderators
Main office 1 Becton Drive Franklin Lakes, NJ 07417-1880 Contact Phone: 201-847-6800 Fax: 201-847-6475 Web site http://www.bd.com Basics Sector: Healthcare Industry: Medical Instruments & Supplies Full Time Employees: 28,018 Background Becton, Dickinson and Company, a medical technology company, manufactures and sells medical devices, instruments, and reagents worldwide. Its BD Medical segment offers medical devices needles, syringes, and intravenous catheters for medication delivery; syringes and pen needles; prefillable drug delivery devices provided to pharmaceutical companies and sold to end-users as drug/device combinations; surgical blades and regional anesthesia needles; critical care monitoring devices; ophthalmic surgical instruments; sharps disposal containers; and home healthcare products, such as elastic bandages. The company's BD Diagnostics segment provides products for the safe collection and transport of diagnostic specimens and instruments for analysis, including preanalytical and diagnostic systems comprising integrated systems for specimen collection, a line of safety-engineered blood collection products and systems, plated media, automated blood culturing systems, molecular testing systems for sexually transmitted diseases and healthcare-associated infections, microorganism identification and drug susceptibility systems, liquid-based cytology systems for cervical cancer screening, and rapid diagnostic assays. Its BD Biosciences segment offers fluorescence activated cell sorters and analyzers, cell imaging systems, monoclonal antibodies and kits for performing cell analysis, reagent systems for life sciences research, tools to aid in drug discovery and growth of living cells and tissue, cell culture media supplements for biopharmaceutical manufacturing, and diagnostic assays. Becton, Dickinson and Company serves hospitals, laboratories, clinics, consumers and retail pharmacies, public health agencies, pharmaceutical and biotech companies, healthcare workers, blood banks, patients, physicians' office practices, and academic and government institutions. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey. Officers Mr. Edward J. Ludwig, 57 Chairman, Chief Exec. Officer, Pres Mr. John R. Considine, 57 Vice Chairman, Chief Financial Officer and Sr. Exec. VP Mr. Vincent A. Forlenza, 54 Exec. VP Mr. Gary M. Cohen, 48 Exec. VP Mr. William A. Kozy, 56 Exec. VP Former officers Mr. Henry P. Becton Dir. Emeritus Sheffield Fellow, Faculty of Engineering, Yale University Henry P. Becton is the retired Vice Chairman of the Board and Chairman of the Executive Committee of Becton Dickinson and Company. The firm was founded in 1897 by his father, the late Maxwell W. Becton, and the late Fairleigh S. Dickinson, Sr. The younger Mr. Becton joined the company in the fall of 1937, the same year he graduated from the Sheffield Scientific School at Yale University. He spent his first year and a half on the road as a salesman for the Company. Returning to the Company's offices in 1939, he was elected to the Board of Directors and he served as Secretary of the Company. In 1944, after he returned from active duty in England during the war, Mr. Becton became the Company's Assistant Treasurer. In 1948, he was made Executive Vice President. From 1961 through February 1987, he was Chairman of the Executive Committee of the Board of Directors. Mr. Becton was elected Chairman of the Board of Directors in May 1972, then Vice Chairman in December 1972. In 1977, he was elected Chairman of the Board again. Then in 1980, at age 65, he retired as Chairman and was Vice Chairman until his retirement from that office in February 1987. He remains Director Emeritus. Mr. Becton has served as a Trustee of Fairleigh Dickinson University from 1948 to 1994. He also served as a member of the Board of Directors of National Community Bank of New Jersey, now National Community Division of The Bank of New York from 1947 to 1993. Long active in a variety of civic, social and community organizations, Mr. Becton has served as borough councilman of Rutherford, New Jersey; Director of the Bergen County and the New Jersey Chambers of Commerce; Chairman of the New Jersey Employers Legislative Committee; President of the New Jersey Symphony Orchestra; and Chairman of the Standing Committee for Clinical Thermometers at the U.S. Bureau of Standards. Mr. Becton resides with his wife in Englewood, New Jersey. Fundamentals Total Cash: 919.64M Total Debt: 1.17B Book Value Per Share: 18.538 Operating Cash Flow: 1.43B Levered Free Cash Flow: 468.17M Revenue: 6.56B Ownership Shares Outstanding: 244.06M Float: 229.80M % Held by Insiders: 5.82% % Held by Institutions : 86.00% Recent developments Becton Dicksinson Gains on Upbeat Note Friday April 4, 3:27 pm ET Becton Dickinson Advances After Analyst Says Company Is Poised to Grow Over Next 2 Years NEW YORK (AP) -- Shares of Becton Dickinson & Co. climbed on Friday after an analyst called the medical technology company "one of the safer plays" in the healthcare sector. Lazard Capital Markets analyst Jeffrey Frelick said in a client note that Becton Dickinson's medical-supply business, which accounts for 70 percent of its sales, was well-insulated from the risk that Medicare will lower reimbursement rates, while its diagnostic business is involved in high-growth areas. Frelick said he expected per-share earnings growth of 12 percent in 2008 as well as 2009 for Becton Dickinson, and expected future earnings to be led by growth in revenue from its safety devices, flow cytometry and pharmaceutical systems. "The company's business is in sound health and, importantly, is not tied to the performance of one or two key products," Frelick said. Frelick rates Becton Dickinson, based in Franklin Lakes, N.J., a "Buy" and maintains a price target of $104. He predicts earnings per share of $4.94 in 2009, ahead of Wall Street estimates. Analysts polled by Thomson Financial expect the company to earn, on average, $4.84 per share in 2009. Shares of Becton Dickinson gained $1.93, or 2.3 percent, to $86.12 in afternoon trading. Selected product line http://cyto.mednet.ucla.edu/instrume.htm Share price King Capital Investment Group http://kingcapital.tripod.com
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post